IGC Pharma, Inc.
IGC
$0.4514
$0.061415.74%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.58% | 34.55% | -6.52% | 27.80% | 17.57% |
| Total Depreciation and Amortization | -8.44% | -1.91% | 8.28% | -10.49% | -1.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.72% | 59.84% | -1.80% | -3.48% | -22.84% |
| Change in Net Operating Assets | -27.36% | -1,038.46% | -113.83% | 203.23% | -96.30% |
| Cash from Operations | -92.74% | 44.57% | -32.23% | 43.15% | -233.08% |
| Capital Expenditure | 55.56% | 33.33% | 6.90% | 23.68% | -153.33% |
| Sale of Property, Plant, and Equipment | 2,825.00% | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.97% | -92.21% | -48.08% | 44.09% | 70.00% |
| Cash from Investing | 508.45% | -36.54% | -60.00% | 50.38% | 59.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 0.00% | 0.00% | -- |
| Issuance of Common Stock | 5.84% | 132.66% | -56.48% | -68.30% | 276.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.71% | 133.33% | -56.55% | -68.33% | 275.86% |
| Foreign Exchange rate Adjustments | 1,150.00% | -- | 100.00% | -650.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.38% | 93.96% | -287.05% | -144.41% | 447.78% |